Young D, Morton R, Bartley J
Division of Otolaryngology-Head and Neck Surgery, Counties-Manukau District Health Board, Auckland, and the Department of Surgery, South Auckland Clinical School, University of Auckland, New Zealand.
J Laryngol Otol. 2010 May;124(5):495-9. doi: 10.1017/S0022215109992519. Epub 2010 Jan 6.
Bacterial biofilms have been implicated in the pathogenesis of chronic rhinosinusitis. In the laboratory setting, ultrasound is effective in disrupting such biofilms; however, few clinical studies have evaluated the role of therapeutic ultrasound in chronic rhinosinusitis.
This study was performed to investigate the short-term effectiveness of therapeutic ultrasound as a treatment modality for chronic rhinosinusitis.
Twenty-two patients with a positive history of chronic rhinosinusitis, according to the criteria set out by the Rhinosinusitis Task Force, together with a previous computed tomography scan compatible with a diagnosis of chronic rhinosinusitis, and who had failed previous, aggressive medical management, were treated with therapeutic pulsed ultrasound at 1 MHz two to three days per week for six sessions. Patients completed an assessment of individual sinus symptom severity and the 20-Item Sino-Nasal Outcome Test questionnaire before treatment, prior to session four and after completion of session six.
Two patients were unable to complete the study protocol. After completion of session six, 18 patients had experienced improvement in symptoms, while two patients noted a worsening of symptoms. Median percentage improvement of the total overall symptom score was 16.7 per cent (Wilcoxon signed rank, p < 0.001). The 20-Item Sino-Nasal Outcome Test score improved by 34.1 per cent (Wilcoxon signed rank, p < 0.0001).
This study demonstrated a significant improvement in chronic rhinosinusitis symptoms after a six-session course of pulsed ultrasound therapy. Treatment with ultrasound alone or combined with antibiotics may provide a strategy to target biofilms on the sinus mucosa. Therapeutic ultrasound warrants further investigation as a potential treatment modality for chronic rhinosinusitis.
细菌生物膜与慢性鼻窦炎的发病机制有关。在实验室环境中,超声波可有效破坏此类生物膜;然而,很少有临床研究评估治疗性超声在慢性鼻窦炎中的作用。
本研究旨在探讨治疗性超声作为慢性鼻窦炎治疗方式的短期疗效。
根据鼻窦炎工作组制定的标准,选取22例有慢性鼻窦炎阳性病史、之前的计算机断层扫描结果符合慢性鼻窦炎诊断且先前积极药物治疗失败的患者,每周两到三天接受1兆赫的治疗性脉冲超声治疗,共六个疗程。患者在治疗前、第四个疗程前和第六个疗程结束后完成个体鼻窦症状严重程度评估和20项鼻窦结局测试问卷。
两名患者无法完成研究方案。第六个疗程结束后,18例患者症状有所改善,2例患者症状恶化。总体症状评分的中位数改善百分比为16.7%(Wilcoxon符号秩检验,p<0.001)。20项鼻窦结局测试评分提高了34.1%(Wilcoxon符号秩检验,p<0.0001)。
本研究表明,经过六个疗程的脉冲超声治疗后,慢性鼻窦炎症状有显著改善。单独使用超声或与抗生素联合使用可能提供一种针对鼻窦黏膜生物膜的治疗策略。治疗性超声作为慢性鼻窦炎的一种潜在治疗方式值得进一步研究。